Serological biomarkers of type III and IV collagen remodeling predict and monitor infliximab treatment response in patients with Inflammatory Bowel Disease

Marta S. Alexdóttir, Arno R. Bourgonje, Morten A. Karsdal, Anne-Christine Bay-Jensen, Klaas Nico Faber, Roberta Loveikyte, Hendrik M. van Dullemen, Marijn C. Visschedijk, Eleonora A. M. Festen, Rinse K. Weersma, Gerard Dijkstra, Joachim H. Mortensen

Onderzoeksoutput › Academic

Vingerafdruk

Duik in de onderzoeksthema's van 'Serological biomarkers of type III and IV collagen remodeling predict and monitor infliximab treatment response in patients with Inflammatory Bowel Disease'. Samen vormen ze een unieke vingerafdruk.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Keyphrases